Mindray Healthcare (300760.SZ) announced first-half results, net profit of 5.069 billion yuan to mother, a decrease of 32.96%

According to the Zhitong Finance App, Mindray Healthcare (300760.SZ) released its 2025 semi-annual report. The company's revenue was 16.743 billion yuan, a year-on-year decrease of 18.45%. Net profit attributable to shareholders of listed companies was 5,069 billion yuan, a year-on-year decrease of 32.96%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 4.949 billion yuan, a year-on-year decrease of 32.94%. Basic earnings per share were $4.184. In addition, it is proposed to distribute a cash dividend of 13.10 yuan (tax included) for every 10 shares to all shareholders.

During the reporting period, the company's international business increased by 5.39% year on year, and the share of international business revenue in the company's overall revenue further increased to about 50%. The current business progress is in line with the company's expectations. International business growth is expected to accelerate in the second half of 2025, and the international in vitro diagnostic production line is expected to grow rapidly.